{"id":963164,"date":"2026-05-14T17:02:00","date_gmt":"2026-05-14T21:02:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-fiscal-second-quarter-2026-results-for-quarter-ended-march-31-2026\/"},"modified":"2026-05-14T17:02:00","modified_gmt":"2026-05-14T21:02:00","slug":"srx-health-solutions-announces-fiscal-second-quarter-2026-results-for-quarter-ended-march-31-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-fiscal-second-quarter-2026-results-for-quarter-ended-march-31-2026\/","title":{"rendered":"SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026"},"content":{"rendered":"
\n

\n Q2 FY26 Marks Operational Inflection Point with Sequential\u00a0<\/em>
\n 23%<\/em>
\n Revenue Growth and 44% Adjusted EBITDA Loss<\/em>
\n
\n 1<\/em>
\n <\/sup>
\n Improvement<\/em>\n <\/p>\n

\n Strengthened Liquidity and Working Capital Position with Cash of $20.5 million as of Quarter End<\/em>\n <\/p>\n

\n Active Cryptocurrency Strategy Outperformed Market by 6%, Reducing Losses by 23% Relative to Buy-and-Hold<\/em>
\n
\n 2<\/em>
\n <\/sup>\n <\/p>\n

NORTH PALM BEACH, Fla., May 14, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the \u201cCompany\u201d or\u00a0“<\/em>SRX“<\/em>), a pet health and wellness company, today announced its financial results for the fiscal second quarter 2026.<\/p>\n

\u201cWith a materially strengthened balance sheet, improved liquidity profile, and significantly improved working capital position, we entered the quarter focused on restoring inventory availability, rebuilding momentum across the Halo\u00ae platform, and positioning the Company for scalable long-term growth,” stated Kent Cunningham, Chief Executive Officer of SRX. “The sequential improvement across key financial metrics, including revenue, gross profit, EPS, and adjusted EBITDA, reflects the meaningful contribution of those initiatives and the operating leverage embedded within the business as normalization continues. As we continue evolving the SRX platform, our strategy remains centered on disciplined capital allocation, operational execution, and long-term value creation. Alongside the continued growth of Halo\u00ae<\/sup>, we are advancing strategic initiatives focused on AI-enabled analytics, digital treasury management, and opportunistic investments across digital assets and other securities designed to diversify the Company\u2019s capital base and enhance long-term shareholder returns.\u201d<\/p>\n

\u201cDespite a challenging market environment in which Bitcoin and Ethereum declined 27% over the six-month trading period, our active cryptocurrency strategy limited losses to 21%, reducing loss exposure by 23% relative to a buy-and-hold approach. This performance reflects the strength of our disciplined, data-driven approach to capital allocation. We also look forward to the planned acquisition of EMJX, which we believe will further enhance our AI-driven capabilities and strengthen our digital asset treasury strategy,\u201d stated Mike Young, member of the Board of Directors.<\/p>\n

On or about May 15, 2026, the Company intends to mail an information statement to shareholders in connection with its previously announced pending acquisition of EMJ Crypto Technologies Inc. (\u201cEMJX\u201d). The information statement is part of the Registration Statement on Form S-4 that was filed by the Company with the Securities and Exchange Commission and can be obtained free of charge on the SEC\u2019s website at www.sec.gov<\/u><\/a> or the Company\u2019s website at srxhealth.com. The acquisition remains subject to certain closing conditions and the Company currently anticipates closing the transaction prior to the end of the fiscal third quarter.<\/p>\n

\n FISCAL SECOND QUARTER 2026 HIGHLIGHTS<\/strong>\n <\/p>\n